论文部分内容阅读
The integrity of the endothelial barrier is a determinant of the prognosis of lipopolysaccharide (LPS)-induced acute lung injury (ALl).In this study,we investigated whether and how Sirtuin 1 (SIRT1) maintained the vascular integrity during ALl.An experimental model of ALl was established in mice through intratracheal administration of LPS (10 mg/kg).LPS stimulation significantly increased the pulmonary permeability and decreased the expression of SIRT1 and tight junction proteins (TJs),including occludin,claudin-5,tight junction protein 1 and tight junction protein 2.Morphological studies showed that LPS induced obvious lung injury with infiammatory cell infiltration in the interstitial and alveolar space,hemorrhage,edema,and the thickened alveolarwall compared to the control mice.Intratracheal administration of the selective SIRT1 activator SRT1720 (6.25 mg/kg) significantly attenuated LPS-induced lung injury,lung hyper-permeability and increased TJs expression,whereas intratracheal administration of the selective SIRT1 inhibitor EX527 (6.25 mg/kg) aggravated LPS-induced ALI.Similar protective effects of SIRT1 on pulmonary cellular permeability were observed in primary human pulmonary microvascular endothelial cells treated with LPS (2 mg/mL) in vitro.We further demonstrated that the RhoA/ROCK signaling pathway was activated in SIRT1 regulation of tight junction permeability.The RhoA/ROCK inhibitor Y-27632 (10 μM)increased the expression of TJs and reversed LPS-or EX527-induced hyper-permeability.In conclusion,SIRT1 ameliorates LPS-induced lung injury via decreasing endothelial tight junction permeability,possibly via RhoA/ ROCK signaling pathway.This finding may contribute to the development of new therapeutic approaches for lung injury.